Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
about
Renal endothelial dysfunction in acute kidney ischemia reperfusion injuryDietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathwayCytochrome P450 eicosanoids in hypertension and renal disease20-HETE and blood pressure regulation: clinical implicationsRenal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient MiceCardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejectionTargeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potentialProtective effect of Lifor solution in experimental renal ischemia-reperfusion injuryRole of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury.Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents20-HETE in acute kidney injury.Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat.Estrogen administered after cardiac arrest and cardiopulmonary resuscitation ameliorates acute kidney injury in a sex- and age-specific manner.Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion InjuryIncreased susceptibility to kidney injury by transfer of genomic segment from SHR onto Dahl S genetic background.Endothelial colony-forming cells ameliorate endothelial dysfunction via secreted factors following ischemia-reperfusion injury.Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury.20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism.Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertensionNovel signalling mechanisms and targets in renal ischaemia and reperfusion injury.Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.Low-dose testosterone protects against renal ischemia-reperfusion injury by increasing renal IL-10-to-TNF-α ratio and attenuating T-cell infiltration.Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.Upregulation of 20-HETE Synthetic Cytochrome P450 Isoforms by Oxygen-Glucose Deprivation in Cortical Neurons.Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.Urinary exosomal expression of activator of G protein signaling 3 in polycystic kidney disease.20-HETE: Hypertension and BeyondPathophysiological and molecular mechanisms involved in renal congestion in a novel rat model
P2860
Q26859947-A8DC325E-BE12-4CB2-9741-AD5BD9F72468Q28235974-DC13590C-70D1-4232-92A3-E10A0EEBA8C6Q28252210-9F6FA82B-89B3-4CC1-BDD0-3450F181FBA9Q28288942-9FD2B612-7CF8-45D5-9B88-A5699B5BB65FQ28398028-FEB41788-16C6-4449-9E7E-3C59E39859BDQ33994820-912A5970-F619-4752-9BB7-06769A2DACF7Q34338086-F011718F-88BB-4792-B35A-626AD76B8F8DQ34348975-A5B299D6-8175-4362-9C2A-E2ADA543D325Q34361800-255AE711-6D92-448A-BC6F-0B9AAFBC0E9DQ34428950-BE8F5B6F-C14E-4B7B-9C12-A45A679E5F16Q35003246-E4AB3DBC-9E62-4726-97A6-EE39A591ABBDQ35135211-544C22C5-697B-4CE4-94FD-B9C54655709BQ35138567-68E673FF-4F91-42A1-9733-EB4AD41AA9E4Q35780521-C5D7BFB1-100C-4283-AB78-9D0DF91B688BQ36104856-9C159227-FB2A-45F5-8D08-D91F6731D54FQ36185479-2B7D560A-B84C-4096-A38F-3375154FC531Q36287886-E8FED986-6887-469E-B3EE-6B980145377FQ36728865-0E0A3BDD-8B61-4978-A566-EDEE14EBADD1Q37337330-537B09B4-8176-42ED-B3B2-17C6A20E7E42Q37340856-B5E6DB67-0370-4B5D-9581-325B36394279Q37417272-373D670D-D62E-47BB-9D14-54A3DB5314A5Q37731230-1DD534C2-F751-4A46-A0E7-47A45AF5A5EAQ37798679-5DA6FFEB-0CD7-4542-B040-B64E9D4AA169Q38083851-4A72012E-124B-44FC-915A-462677477363Q39431317-312D223E-26D7-402E-B55F-D59B4E031C9CQ40998899-6549C9C8-5FC9-4F59-94C1-1678B837A6DCQ42926298-3D38DEC4-FAB3-4E16-A970-E5030F0C5BBDQ48326681-D365DA82-1DE8-4D72-AF97-C7075209C4FEQ51239324-F1A4362E-EE01-4CCC-B058-B78237D2C759Q55265318-997A351D-0DD3-4982-93A1-A447C9B72C4FQ57210352-1CE2F999-CCB6-4E02-86EE-C9E4BE6F026CQ59136091-4E0C11CB-1E1C-4B08-93A7-0CBC4B42188E
P2860
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
@ast
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
@en
type
label
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
@ast
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
@en
prefLabel
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
@ast
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
@en
P2093
P2860
P356
P1433
P1476
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
@en
P2093
Brian D Shames
Kevin R Regner
Meghan E McMullen
Richard J Roman
Robert P Ryan
Scott K Van Why
Steven R Ledbetter
Vijay L Manthati
P2860
P2888
P304
P356
10.1038/KI.2008.600
P407
P577
2008-12-03T00:00:00Z
P5875
P6179
1037866501